Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
26 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Aegerion Pharmaceuticals Articles
FDA approves Aegerion's new orphan drug Juxtapid for rare cholesterol disorder
28 December 2012
US FDA approves ThromboGenics' Jetrea; advisory backing for Aegerion's lomitapide
19 October 2012
Aegerion files for lomitapide approval in USA and Europe
7 March 2012
Showing 1-3 of 3 articles
1
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth